Walter Cazzaniga (@waltercazzaniga) 's Twitter Profile
Walter Cazzaniga

@waltercazzaniga

ID: 1273387688

calendar_today16-03-2013 21:51:18

108 Tweet

93 Followers

265 Following

YAU Working Group Penile & Testis Cancer (@yaupenile_tesca) 's Twitter Profile Photo

🚨don't miss: tomorrow: Inês Santiago, Walter Cazzaniga with other great panelists will discuss a case about Seminoma Stage IIB. What are the therapy options? Purple area, eURO auditorium 2 🟣 #EAU24

🚨don't miss: tomorrow: <a href="/dr_inessantiago/">Inês Santiago</a>,  <a href="/WalterCazzaniga/">Walter Cazzaniga</a> with other great panelists will discuss a case about Seminoma Stage IIB.
What are the therapy options?

Purple area, eURO auditorium 2 🟣
#EAU24
DrBagrodia (@adityabagrodia) 's Twitter Profile Photo

Long-term QOL of #GCT patients according to adj treatment pubmed.ncbi.nlm.nih.gov/38658465/ Crucial data informing impact of RPLND, chemo, XRT in CSI and >CSI GCT patients. Surveillance preferred option, but this can guide discussion! Sia Daneshmand, M.D. Scott Eggener Phillip Pierorazio nirm

European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

Measure serum tumour markers both before and after orchidectomy taking into account half-life kinetics of 5-7 days for AFP and 1-3 days for β-hCG. #TesticularCancer #EAUguidelines uroweb.org/guidelines/tes…

𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD (@ricbertolo) 's Twitter Profile Photo

👏🏼 Dr. Tappero for leading this project 🧑‍🧑‍🧒‍🧒 968 PN vs. 325 RN pts treated for T1b-T2 #renal masses 🔑points: •rate of #AKI lower s/p PN 17% vs. 58%; p< 0.001). •1 yr after surgery, %pts. who recovered ≥ 90% of baseline #eGFR higher s/p PN (51% vs. 16%). •rate

👏🏼 Dr. Tappero for leading this project 

🧑‍🧑‍🧒‍🧒 968 PN vs. 325 RN pts treated for T1b-T2 #renal masses

🔑points:

•rate of #AKI lower s/p PN 17% vs. 58%; p&lt; 0.001). 

•1 yr after surgery, %pts. who recovered ≥ 90% of baseline #eGFR higher s/p PN (51% vs. 16%).

•rate
Samson W. Fine, MD (@rovingatuscap) 's Twitter Profile Photo

Dr. David Nicol (The Royal Marsden NHS Foundation Trust) with the final talk of GU Pathology Society (GUPS) Virtual Education Series event on Germ Cell Tumors: Beyond the Usual TOPIC: Clinical Management of Advanced/Metastatic Germ Cell Tumors #gupath #testicularcancer ROHIT MEHRA Sounak Gupta

Dr. David Nicol (<a href="/royalmarsdenNHS/">The Royal Marsden NHS Foundation Trust</a>) with the final talk of <a href="/GU_Path_Society/">GU Pathology Society (GUPS)</a> Virtual Education Series event on Germ Cell Tumors: Beyond the Usual

TOPIC: Clinical Management of Advanced/Metastatic Germ Cell Tumors #gupath #testicularcancer <a href="/drmehrarohit/">ROHIT MEHRA</a> <a href="/Shounak_Gupta/">Sounak Gupta</a>
Michael Stifelman (@mdstifelman) 's Twitter Profile Photo

What the what! RRP being done by surgeon Xu Zhang in Rome with patient in Beijing China. Latency is 125 Ms. 5G telecommunication. Looks as if surgeon is in the room. The future is now! Pandora box has now been opened. Note surgeon and console in China as a backup.

What the what!  RRP being done by surgeon Xu Zhang in Rome with patient in Beijing China. Latency is 125 Ms.  5G telecommunication. Looks as if surgeon is in the room. The future is now! Pandora box has now been opened. Note  surgeon and console in China as a backup.
Torgrim Tandstad (@torgrimtandstad) 's Twitter Profile Photo

Results of primary RPLND in low-volume metastatic seminomatous testicular cancer, treated in spezialized centers as standard treatment according to #SWENOTECA X. Potential reduced long-term morbidity and mortality compared to primary radiotherapy or chemotherapy.

Results of primary RPLND in low-volume metastatic seminomatous testicular cancer, treated in spezialized centers as standard treatment according to #SWENOTECA X. Potential reduced long-term morbidity and mortality compared to primary radiotherapy or chemotherapy.
European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

In patients with stage I seminoma, do not perform adjuvant treatment in patients at very low risk of recurrence (tumour size < 4 cm and no rete testis invasion). #TesticularCancer #EAUguidelines uroweb.org/guidelines/tes…

Christian D. Fankhauser (@cdfankhauser) 's Twitter Profile Photo

🔬🧪📢 miRNA371 in Testicular Cancer: miRNA371 shows promise for earlier detection of testicular cancer compared to conventional methods. However, defining the optimal cut-off to limit false positives is key. In this retrospective analysis, using a CE-approved test on

Knowuro (@knowuro) 's Twitter Profile Photo

Hello #residents! The FEBU exam is just a month away. Feeling overwhelmed? We've created a 28-day study plan! It might also be helpful for other urology board exams. Download the free PDF here: bit.ly/3BCJL7y Good luck! 💪📚 #FEBU #StudyPlan #GoodLuck #urology #exam

Hello #residents! 

The FEBU exam is just a month away. Feeling overwhelmed? We've created a 28-day study plan! It might also be helpful for other urology board exams. Download the free PDF here: bit.ly/3BCJL7y Good luck! 💪📚 

#FEBU #StudyPlan #GoodLuck #urology #exam
Knowuro (@knowuro) 's Twitter Profile Photo

🎉Excited to announce our upcoming book for aspiring urologists & first-year residents! Covering progress notes, night shifts, DJ placements & more. Peer-reviewed by amazing urologists! Get early access on the Knowuro Reader App or subscribe for updates! knowuro.com/books/unboxed/

🎉Excited to announce our upcoming book for aspiring urologists &amp; first-year residents!
Covering progress notes, night shifts, DJ placements &amp; more. Peer-reviewed by amazing urologists!

Get early access on the Knowuro Reader App or subscribe for updates!
knowuro.com/books/unboxed/
European Urology (@euplatinum) 's Twitter Profile Photo

Words of Wisdom Wednesday: Re: Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office by Walter Cazzaniga and David Nicol Read the full

Words of Wisdom Wednesday: Re: Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office by <a href="/WalterCazzaniga/">Walter Cazzaniga</a> and David Nicol

Read the full
Sia Daneshmand, M.D. (@siadaneshmand) 's Twitter Profile Photo

Excellent discussion by Clint Cary, MD MPH MBA #GU25 following Axel Heidenreich’s long term followup of COTRIMS trial. Surgery for early metastatic seminoma. Appreciate continuous efforts to improve on already excellent curative outcomes with #RPLND alone. #SEMS. Testicular Cancer Society Testicular Cancer

Excellent discussion by <a href="/ClintCaryMD/">Clint Cary, MD MPH MBA</a> #GU25 following Axel Heidenreich’s long term followup of COTRIMS trial. Surgery for early metastatic seminoma. Appreciate continuous efforts to improve on already excellent curative outcomes with #RPLND alone. #SEMS. <a href="/TCSociety/">Testicular Cancer Society</a> <a href="/TestesCancer/">Testicular Cancer</a>
Knowuro (@knowuro) 's Twitter Profile Photo

🚀Finally, Urology: Unboxed is fully published in our App! You can now pre-order the physical book. Made for first-year urology residents—it would be a great gift! If you're interested or know someone starting their journey, share this link: knowuro.com/books/unboxed/

🚀Finally, Urology: Unboxed is fully published in our App! You can now pre-order the physical book.

Made for first-year urology residents—it would be a great gift! If you're interested or know someone starting their journey, share this link: knowuro.com/books/unboxed/
Knowuro (@knowuro) 's Twitter Profile Photo

A huge thank you to our reviewers! Their expertise was invaluable in elevating the content. We all worked on this project with the same aim: to support young residents and aspiring urologists in starting their careers smoothly. Excited to share this collaboration!

A huge thank you to our reviewers! Their expertise was invaluable in elevating the content. We all worked on this project with the same aim: to support young residents and aspiring urologists in starting their careers smoothly. Excited to share this collaboration!
Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

[3/3] Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours. #CRUKFunded #tyacancer

[3/3]

Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours.

#CRUKFunded #tyacancer